Clarithromycin USP 500 mg

Business Unit: Human

Medicine Type: Tablet

Generic Name: Clarithromycin USP 500 mg

Therapeutic Class: Macrolide Antibiotic

Indication: Rith is a preparation of Clarithromycin USP which is a broad-spectrum macrolide antibiotic. It is bacteriostatic in nature and works by inhibiting the Bacterial Protein synthesis through binding with bacterial 50s ribosomal subunits. Rith is indicated in upper respiratory tract infection (sinusitis, pharyngitis), lower respiratory tract infection (acute and chronic bronchitis, pneumonia, atypical pneumonia, Community-acquired pneumonia), skin and soft tissue infection, adjunct in the treatment of duodenal ulcers to eradicate of Helicobacter pylori.

Dosage & Administration: Rith (Clarithromycin) may be given with or without meals. Adults (12 years or above): 250 mg twice daily for 7 days. Dose may be increased to 500 mg twice daily for up to 14 days in pneumonia or severe infections. Combination therapy for H. pylori infection: Rith (Clarithromycin) 500 mg twice daily in combination with Amoxicillin 1000 mg twice daily and Omeprazole 20 mg twice daily should be continued for 10 days.

Preparation: 2x7 Tablet